8 In addition to the two candidate vaccines described above, more recently two other Ebola vaccine programmes have met the initially proposed pre-clinical trial criteria. These are a heterologous combination of two replication deficient recombinant vectors: human adenovirus 26 and modified vaccinia virus Ankara, both expressing ZEBOV GP ... More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.